| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGGCAGCUGGGGUAAGGAGUUCAAGGCAGCGCCCACACCCGGGGGCUCU… | 2971 nt | 0.5311 | |
| GCUUUCACCACUGCCCCUCCCGGGGGGACCUGAAGGAGAGGGUUUGAGG… | 2466 nt | 0.4838 | |
| GCUUUCACCACUGCCCCUCCCGGGGGGACCUGAAGGAGAGGGUUUGAGG… | 2424 nt | 0.4814 | |
| AUUCCUGAGAUACCUGCAGCUGUCAGCCCUGCCGUCUAGAUGGUAAACA… | 2091 nt | 0.4481 | |
| AGGCAGCUGGGGUAAGGAGUUCAAGGCAGCGCCCACACCCGGGGGCUCU… | 3016 nt | 0.5312 | |
| AGGCAGCUGGGGUAAGGAGUUCAAGGCAGCGCCCACACCCGGGGGCUCU… | 2980 nt | 0.5302 | |
| AGGCAGCUGGGGUAAGGAGUUCAAGGCAGCGCCCACACCCGGGGGCUCU… | 2938 nt | 0.5320 | |
| AGGCAGCUGGGGUAAGGAGUUCAAGGCAGCGCCCACACCCGGGGGCUCU… | 2899 nt | 0.5267 | |
| AGGCAGCUGGGGUAAGGAGUUCAAGGCAGCGCCCACACCCGGGGGCUCU… | 2890 nt | 0.5325 | |
| AGGCAGCUGGGGUAAGGAGUUCAAGGCAGCGCCCACACCCGGGGGCUCU… | 2887 nt | 0.5317 |
This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilms tumor. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation codon upstream of, and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated. [provided by RefSeq, Mar 2015] CIViC Summary for WT1 Gene WT1 is a tumor suppressor gene associated with the development of Wilms' Tumor, from which it was named. Mutations in exon 7 and 9 of WT1 have been recurrently identified in acute myeloid leukemia and associated with poorer prognosis and chemotherapy resistance.
A study in mice demonstrated that WT1 expression is progressively restricted postnatally and becomes exclusive to the epicardium by postnatal day 21, serving as a specific marker for tagging and tracing epicardial-derived cells (EDCs) in a model of arrhythmogenic cardiomyopathy [Yuan et al. DOI:10.1161/CIRCULATIONAHA.120.052928].